Literature DB >> 27106918

Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease.

Kenji Norimatsu1, Takashi Kuwano1, Shin-Ichiro Miura2,3, Tomohiko Shimizu1, Yuhei Shiga1, Yasunori Suematsu1, Yuiko Miyase1, Sen Adachi1, Ayumi Nakamura1, Satoshi Imaizumi1, Atsushi Iwata1, Hiroaki Nishikawa1, Yoshinari Uehara1,4, Keijiro Saku1,4.   

Abstract

We hypothesized that cholesterol efflux capacity is more useful than the lipid profile as a marker of the presence and the severity of coronary artery disease (CAD). Therefore, we investigated the associations between the presence and the severity of CAD and both the percentage of cholesterol efflux capacity and total cholesterol efflux capacity and the lipid profile including the high-density lipoprotein cholesterol (HDL-C) level in patients who underwent coronary computed tomography angiography (CTA). The subjects consisted of 204 patients who were clinically suspected to have CAD and underwent CTA. We isolated HDL from plasma by ultracentrifugation and measured the percentage of cholesterol efflux capacity using 3H-cholesterol-labeled J774 macrophage cells and calculated total cholesterol efflux capacity as follows: the percentage of cholesterol efflux capacity/100× HDL-C levels. While the percentage of cholesterol efflux capacity was not associated with the presence or the severity of CAD, total cholesterol efflux capacity and HDL-C in patients with CAD were significantly lower than those in patients without CAD. In addition, total cholesterol efflux capacity and HDL-C, but not the percentage of cholesterol efflux capacity, significantly decreased as the number of coronary arteries with significant stenosis increased. Total cholesterol efflux capacity was positively correlated with HDL-C, whereas the percentage of cholesterol efflux capacity showed only weak association. In a logistic regression analysis, the presence of CAD was independently associated with total cholesterol efflux capacity, in addition to age and gender. Finally, a receiver-operating characteristic curve analysis indicated that the areas under the curves for total cholesterol efflux capacity and HDL-C were similar. In conclusion, the percentage of cholesterol efflux capacity using the fixed amount of isolated HDL was not associated with CAD. On the other hand, the calculated total cholesterol efflux capacity that was dependent of HDL-C levels had a significant correlation with the presence of CAD.

Entities:  

Keywords:  Cholesterol efflux capacity; Coronary artery disease; Coronary computed tomography angiography; High-density lipoprotein cholesterol

Mesh:

Substances:

Year:  2016        PMID: 27106918     DOI: 10.1007/s00380-016-0837-7

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  31 in total

Review 1.  Cell cholesterol efflux: integration of old and new observations provides new insights.

Authors:  G H Rothblat; M de la Llera-Moya; V Atger; G Kellner-Weibel; D L Williams; M C Phillips
Journal:  J Lipid Res       Date:  1999-05       Impact factor: 5.922

2.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

3.  High-Density Lipoprotein (HDL) Phospholipid Content and Cholesterol Efflux Capacity Are Reduced in Patients With Very High HDL Cholesterol and Coronary Disease.

Authors:  Anandita P Agarwala; Amrith Rodrigues; Marjorie Risman; Mary McCoy; Kevin Trindade; Liming Qu; Marina Cuchel; Jeffrey Billheimer; Daniel J Rader
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-04-02       Impact factor: 8.311

4.  Clinical significance of the coronary calcification score by multidetector row computed tomography for the evaluation of coronary stenosis in Japanese patients.

Authors:  Ryoko Mitsutake; Hideya Niimura; Shin-ichiro Miura; Bo Zhang; Atsushi Iwata; Hiroaki Nishikawa; Akira Kawamura; Koichiro Kumagai; Kazuyuki Shirai; Akira Matsunaga; Keijiro Saku
Journal:  Circ J       Date:  2006-09       Impact factor: 2.993

Review 5.  High-density lipoprotein--the clinical implications of recent studies.

Authors:  D J Gordon; B M Rifkind
Journal:  N Engl J Med       Date:  1989-11-09       Impact factor: 91.245

6.  HDL cholesterol efflux capacity and incident cardiovascular events.

Authors:  Anand Rohatgi; Amit Khera; Jarett D Berry; Edward G Givens; Colby R Ayers; Kyle E Wedin; Ian J Neeland; Ivan S Yuhanna; Daniel R Rader; James A de Lemos; Philip W Shaul
Journal:  N Engl J Med       Date:  2014-11-18       Impact factor: 91.245

7.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Authors:  William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub
Journal:  N Engl J Med       Date:  2011-11-15       Impact factor: 91.245

8.  Effects of torcetrapib in patients at high risk for coronary events.

Authors:  Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

9.  Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks.

Authors:  Xin-Min Li; Wai Hong Wilson Tang; Marian K Mosior; Ying Huang; Yuping Wu; William Matter; Vivian Gao; David Schmitt; Joseph A Didonato; Edward A Fisher; Jonathan D Smith; Stanley L Hazen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-03-21       Impact factor: 8.311

10.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

View more
  7 in total

1.  Associations Between High Levels of High-Density Lipoprotein Cholesterol and the Presence and Severity of Coronary Artery Disease in Patients Who Have Undergone Coronary Computed Tomography Angiography.

Authors:  Kohei Tashiro; Hiroko Inoue; Yuhei Shiga; Yohei Tsukihashi; Tomoki Imaizumi; Kenji Norimatsu; Yoshiaki Idemoto; Takashi Kuwano; Makoto Sugihara; Hiroaki Nishikawa; Yousuke Katsuda; Shin-Ichiro Miura
Journal:  J Clin Med Res       Date:  2020-11-03

2.  High-density lipoprotein cholesterol efflux capacity and incidence of coronary artery disease and cardiovascular mortality: a systematic review and meta-analysis.

Authors:  Holger Thiele; Petra Buettner; Wenke Cheng; Maciej Rosolowski; Julia Boettner; Steffen Desch; Alexander Jobs
Journal:  Lipids Health Dis       Date:  2022-05-28       Impact factor: 4.315

3.  Cholesterol Efflux and Collateral Circulation in Chronic Total Coronary Occlusion: Effect-Circ Study.

Authors:  Seonhwa Lee; Jung Mi Park; Soo-Jin Ann; Moonjong Kang; Eun Jeong Cheon; Dan Bi An; Yu Ri Choi; Chan Joo Lee; Jaewon Oh; Sungha Park; Seok-Min Kang; Sang-Hak Lee
Journal:  J Am Heart Assoc       Date:  2021-02-26       Impact factor: 5.501

4.  The pleiotropic vasoprotective functions of high density lipoproteins (HDL).

Authors:  Guilaine Boyce; Emily Button; Sonja Soo; Cheryl Wellington
Journal:  J Biomed Res       Date:  2017-05-26

5.  Ezetimibe Monotherapy Reduces Serum Levels of Platelet-Activating Factor Acetylhydrolase in Patients With Dyslipidemia.

Authors:  Kanako Tano; Yasunori Suematsu; Kohei Tashiro; Naoko Kumagai-Koyanagi; Yoshino Matsuo; Takashi Kuwano; Shin-Ichiro Miura
Journal:  J Clin Med Res       Date:  2019-10-04

6.  Association Between the Level of Low-Density Lipoprotein Cholesterol and Coronary Atherosclerosis in Patients Who Have Undergone Coronary Computed Tomography Angiography.

Authors:  Hiroko Inoue; Yuhei Shiga; Kohei Tashiro; Yuto Kawahira; Yasunori Suematsu; Yoshiaki Idemoto; Kanako Tano; Takashi Kuwano; Makoto Sugihara; Hiroaki Nishikawa; Yousuke Katsuda; Shin-Ichiro Miura
Journal:  Cardiol Res       Date:  2020-12-11

7.  Associations between High-Density Lipoprotein Functionality and Major Adverse Cardiovascular Events in Patients Who Have Undergone Coronary Computed Tomography Angiography.

Authors:  Hiroko Inoue; Yuhei Shiga; Kenji Norimatsu; Kohei Tashiro; Makito Futami; Yasunori Suematsu; Makoto Sugihara; Hiroaki Nishikawa; Yousuke Katsuda; Shin-Ichiro Miura
Journal:  J Clin Med       Date:  2021-05-30       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.